Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine

Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine

US Patent 8669273 · Granted Mar 11, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Air handling systems and controls for internal combustion engines operating with2025
Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-2722020
Antineoplastic combinations containing HKI-272 and vinorelbine2018
Antineoplastic combinations containing HKI-272 and vinorelbine2016
Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine2016
Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine2016
Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine2016
Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine2016
Treatment regimen utilizing neratinib for breast cancer2015
Cut-point in PTEN protein expression that accurately identifies tumors and is pr2012